How to Get Metformin in Colorado

Why Metformin Remains a First-Line Drug

Metformin has been the default starting medication for type 2 diabetes since the late 1990s, and that position has not changed. The American Diabetes Association (ADA) 2024 Standards of Care lists metformin as first-line pharmacotherapy for most adults with type 2 diabetes, citing its glucose-lowering efficacy, weight neutrality, low hypoglycemia risk, and decades of cardiovascular outcome data [1].

The drug's durability traces back to UKPDS 34, a landmark trial published in The Lancet in 1998. That study enrolled 1,704 overweight patients with newly diagnosed type 2 diabetes and found that metformin reduced diabetes-related mortality by 42% compared with conventional dietary therapy alone (P<0.002) [2]. No other oral diabetes drug had demonstrated a mortality benefit of that magnitude at the time, and the finding cemented metformin's role in every major guideline that followed.

Generic metformin is manufactured by dozens of companies. A 30-day supply of immediate-release 500 mg tablets costs between $4 and $20 at most retail pharmacies, making it one of the least expensive prescription medications in the United States [3]. Colorado residents have multiple pathways to obtain it.

Telehealth Prescribing in Colorado

Colorado law permits licensed healthcare providers to prescribe metformin through telehealth, and the state does not require an initial in-person visit for this class of medication. A synchronous video or audio consultation with a provider who holds an active Colorado medical license satisfies the prescribing requirements.

The Colorado Medical Board updated its telemedicine policy in alignment with the Ryan Haight Act and state-specific telehealth statutes, confirming that a valid provider-patient relationship can be established via real-time audiovisual communication. This means a Colorado resident in Durango, Grand Junction, or any rural county can receive a metformin prescription without driving to a brick-and-mortar clinic.

Telehealth platforms typically follow a structured workflow. You complete a medical intake, upload or share recent lab results, and connect with a licensed prescriber. If labs are older than 90 days or unavailable, most platforms will order new bloodwork through a partnered lab network before writing the prescription. The entire process, from intake to pharmacy notification, often takes 24 to 72 hours. Some platforms fulfill same-day prescriptions when labs are already on file.

The ADA recommends measuring HbA1c at least twice yearly in patients meeting treatment goals and quarterly in those whose therapy has changed [1]. Telehealth providers in Colorado follow the same monitoring cadence as in-person clinics.

Required Labs Before Starting Metformin

No responsible provider will prescribe metformin without reviewing baseline lab work. The FDA-approved prescribing information for metformin requires assessment of renal function before initiation because the drug is cleared almost entirely by the kidneys [3].

Here is what most Colorado providers will order:

HbA1c. This test reflects average blood glucose over the preceding 8 to 12 weeks. A value of 6.5% or higher confirms a diabetes diagnosis. Values between 5.7% and 6.4% indicate prediabetes, for which metformin may be prescribed off-label based on ADA guidance [1].

Fasting plasma glucose. A single fasting glucose of 126 mg/dL or higher, confirmed on a repeat test, meets the diagnostic threshold for type 2 diabetes [1].

Basic metabolic panel with eGFR. The estimated glomerular filtration rate (eGFR) determines whether metformin can be used safely. Per the FDA label, metformin is contraindicated in patients with an eGFR below 30 mL/min/1.73 m². For patients with an eGFR between 30 and 45, initiation is not recommended, though continuation at a reduced dose may be appropriate [3]. These thresholds replaced the older serum creatinine cutoffs in 2016 after the FDA reviewed post-marketing safety data from more than 65,000 patients.

Hepatic function tests. While not an absolute requirement, many providers check liver enzymes at baseline because metformin is sometimes prescribed alongside medications that affect hepatic metabolism.

Vitamin B12. The ADA notes that long-term metformin use is associated with vitamin B12 deficiency, observed in up to 30% of patients in some cohorts [4]. Baseline measurement allows providers to track changes over time.

Labs can be drawn at any Quest Diagnostics, Labcorp, or independent laboratory in Colorado. Results are typically available within 24 to 48 hours.

Who Can Prescribe Metformin in Colorado

Three categories of providers hold independent or supervised prescriptive authority in Colorado.

Physicians (MD/DO). Any physician with an active, unrestricted Colorado medical license and a valid DEA registration (if required for the practice setting) can prescribe metformin. Family medicine, internal medicine, and endocrinology physicians write the majority of metformin prescriptions statewide.

Nurse practitioners (NP). Colorado grants NPs full practice authority after completion of a mentorship period. Under Colorado Revised Statutes § 12-255-112, NPs with prescriptive authority can prescribe metformin independently without physician oversight. This is significant for rural Colorado, where NPs serve as primary care providers in many communities.

Physician assistants (PA). PAs in Colorado prescribe under a collaborative agreement with a supervising physician, per Colorado Revised Statutes § 12-240-107. The supervising physician does not need to be physically present at the time of prescribing, which allows PAs in telehealth settings to write metformin prescriptions with appropriate oversight documentation in place.

Pharmacists in Colorado cannot independently prescribe metformin. However, pharmacists can enter into collaborative practice agreements with physicians to adjust metformin doses within pre-approved protocols, a model used in some integrated health systems.

Colorado Medicaid and Insurance Coverage

Colorado Medicaid, administered through Health First Colorado, covers metformin for the treatment of type 2 diabetes. Generic metformin immediate-release and extended-release tablets are listed on the state's preferred drug list, meaning they do not require prior authorization when prescribed for an FDA-approved indication [5].

Coverage becomes more complicated for off-label uses. Colorado Medicaid does not cover metformin prescribed solely for prediabetes, insulin resistance without a diabetes diagnosis, or weight management. Providers who want Medicaid to cover metformin for a patient with prediabetes must submit a prior authorization request, and approval is not guaranteed.

The Diabetes Prevention Program (DPP) trial, published in the New England Journal of Medicine in 2002, demonstrated that metformin 850 mg twice daily reduced the incidence of type 2 diabetes by 31% over 2.8 years compared with placebo in high-risk adults with prediabetes (N=3,234) [6]. Despite this evidence, most state Medicaid programs, including Colorado's, have been slow to add prediabetes as a covered indication.

For patients with commercial insurance, metformin is almost universally covered at the lowest formulary tier. Copays typically range from $0 to $10 for a 30-day supply. Patients on high-deductible plans who pay out of pocket will find cash prices under $20 at most Colorado pharmacies.

The GoodRx and RxSaver discount platforms report Colorado-specific prices as low as $4 for 60 tablets of metformin 500 mg IR at Walmart, Costco, and select King Soopers locations.

503A Compounding Pharmacies in Colorado

Colorado licenses 503A compounding pharmacies under the State Board of Pharmacy, and these pharmacies can prepare and ship compounded metformin formulations within the state. A 503A pharmacy compounds medications pursuant to individual patient prescriptions, as distinguished from 503B outsourcing facilities that produce larger batches without patient-specific prescriptions.

Why would someone need compounded metformin? The most common reason is formulation. Some patients cannot tolerate standard tablets or need a liquid suspension, a flavored solution, or a custom dose strength not available commercially. Pediatric patients and patients with dysphagia are typical candidates.

The FDA's guidance on compounding under Section 503A of the Federal Food, Drug, and Cosmetic Act requires that 503A pharmacies compound in response to a valid prescription, use ingredients that meet USP or NF standards, and not compound drugs that are essentially copies of commercially available products unless there is a documented clinical difference [7].

Colorado-based 503A pharmacies can ship compounded metformin to patients anywhere within the state. Interstate shipping from a 503A pharmacy requires compliance with both the originating and receiving state's pharmacy laws, which adds complexity. Patients in Colorado seeking compounded metformin should confirm that their chosen pharmacy holds an active Colorado Board of Pharmacy license.

Transferring a Metformin Prescription to Colorado

If you are moving to Colorado or visiting for an extended period, you can transfer an existing metformin prescription from another state. Colorado follows the standard prescription transfer protocol outlined by the National Association of Boards of Pharmacy (NABP).

The process is straightforward. Contact a Colorado pharmacy and provide your current pharmacy's name, phone number, and prescription number. The receiving pharmacist will call the originating pharmacy and complete a verbal transfer. Electronic transfers between pharmacies using the same software system (e.g., two CVS locations) can happen within minutes.

Metformin is not a controlled substance. It does not appear on any DEA schedule, so there are no federal transfer restrictions beyond the standard requirements for legend drugs. Colorado does not impose additional state-level barriers to transferring non-controlled prescriptions.

One caveat: a transferred prescription carries the remaining refills from the original prescription. If your previous provider wrote for 90 days with three refills, and you used one refill, the Colorado pharmacy will honor the remaining two refills. After those expire, you will need a new prescription from a Colorado-licensed provider.

Prior Authorization: When It Applies and What You Need

Prior authorization for metformin in Colorado is uncommon for standard indications but does arise in specific situations.

When PA is typically required:

• Off-label prescribing (prediabetes, PCOS, weight management) under Medicaid
• Brand-name Glucophage when a generic is available
• Extended-release formulations on certain commercial formularies that prefer IR

Documentation a Colorado insurer may request:

• Diagnosis code (ICD-10: E11.9 for type 2 diabetes, R73.03 for prediabetes)
• Recent HbA1c and fasting glucose values
• eGFR confirming renal function above the contraindication threshold
• Documentation of prior lifestyle intervention (for prediabetes claims)
• Clinical rationale for brand or ER formulation if generic IR is available

As Dr. Robert Gabbay, Chief Scientific and Medical Officer of the ADA, stated in the ADA's 2024 Standards of Care update: "Metformin remains the preferred initial pharmacologic agent for type 2 diabetes in most patients due to its efficacy, safety, and low cost" [1]. Insurers rarely push back on a drug their own guidelines endorse as first-line.

Processing time for prior authorization in Colorado averages 24 to 72 hours for commercial plans and up to 10 business days for Medicaid. Urgent or expedited requests, submitted when a patient faces immediate clinical need, are typically reviewed within 24 hours.

Metformin Dosing and What to Expect

The standard starting dose is 500 mg once or twice daily, taken with meals. The ADA and the FDA prescribing information recommend gradual titration: increase by 500 mg weekly until reaching the target dose of 1,500 to 2 to 000 mg per day, divided into two or three doses [3].

Extended-release (ER) metformin is dosed once daily, usually with the evening meal. The ER formulation reduces gastrointestinal side effects, which are the most common reason patients discontinue metformin. In a meta-analysis of 26 randomized trials (N=4,570), GI adverse events occurred in 25.5% of patients on immediate-release metformin versus 15.3% on extended-release (RR 0.62 to 95% CI 0.49 to 0.78) [8].

Expected clinical results depend on baseline HbA1c. Metformin monotherapy typically lowers HbA1c by 1.0 to 1.5 percentage points [1]. A patient starting at 8.0% might expect to reach 6.5% to 7.0% after 3 to 6 months of consistent use at therapeutic doses.

Weight effects are modest. UKPDS 34 reported that metformin-treated patients gained less weight than those on sulfonylureas or insulin [2]. Some patients lose 2 to 3 kg in the first year, though metformin is not classified as a weight-loss medication.

The DPP follow-up study (DPPOS) tracked participants for 15 years and found that the metformin group maintained a 18% reduction in diabetes incidence compared with placebo (hazard ratio 0.82 to 95% CI 0.72 to 0.93), suggesting durable benefit even after more than a decade of use [9].

Safety Considerations Specific to Colorado

Colorado's geography introduces one clinical consideration that providers elsewhere may not emphasize. Metformin carries a boxed warning for lactic acidosis, a rare but serious complication. The risk increases with renal impairment, hepatic disease, excessive alcohol intake, and states of tissue hypoxia [3].

Colorado's mean elevation is 6,800 feet, the highest of any U.S. state. At altitude, arterial oxygen partial pressure is lower than at sea level. While healthy individuals acclimatize without issue, patients with underlying cardiopulmonary disease may experience reduced oxygen delivery at high altitude. The FDA label notes that conditions predisposing to tissue hypoxia increase lactic acidosis risk [3].

In practice, millions of Colorado residents take metformin at altitude without incident. The risk is theoretical for healthy patients and clinically relevant only for those with concurrent hypoxia from heart failure, severe COPD, or acute illness. Colorado providers routinely prescribe metformin at all elevations, but they may monitor more closely in patients with cardiopulmonary comorbidities.

The actual incidence of metformin-associated lactic acidosis is estimated at 3 to 10 cases per 100,000 patient-years, based on a Cochrane systematic review of 347 trials (N=70,490) that found no increase in lactic acidosis with metformin compared with other antidiabetic treatments [10].